APO Research
Talk to an analyst

APO RESEARCH · REPORT

Total Intravenous Anesthesia (TIVA)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Total Intravenous Anesthesia (TIVA) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025198 pages

Choose your research edition.

Industry ResearchTotal Intravenous Anesthesia (TIVA) Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Total Intravenous Anesthesia (TIVA) Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Total Intravenous Anesthesia (TIVA) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Total Intravenous Anesthesia (TIVA) Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Total Intravenous Anesthesia (TIVA) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Total Intravenous Anesthesia (TIVA) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Total Intravenous Anesthesia (TIVA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Total Intravenous Anesthesia (TIVA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Total Intravenous Anesthesia (TIVA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Total Intravenous Anesthesia (TIVA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Total Intravenous Anesthesia (TIVA) include Mylan, Hengrui, B. Braun Medical, AbbVie, Astrazeneca, Piramal, Nhwa, Maruishi and Lunan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Total Intravenous Anesthesia (TIVA) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Total Intravenous Anesthesia (TIVA) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Total Intravenous Anesthesia (TIVA) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Total Intravenous Anesthesia (TIVA) market size, projected growth trends, production technologies, key applications, and end-use industries.

Total Intravenous Anesthesia (TIVA) Segment by Company

Mylan

Hengrui

B. Braun Medical

AbbVie

Astrazeneca

Piramal

Nhwa

Maruishi

Lunan

Hikma Pharmaceuticals

Fresenius-Kabi

Baxter Healthcare

Total Intravenous Anesthesia (TIVA) Segment by Type

Barbiturates

Propofol

Midazolam

Etomidate

Others

Total Intravenous Anesthesia (TIVA) Segment by Application

Orthopedic

Cosmetic Surgeries

Predominantly Emergency

Others

Total Intravenous Anesthesia (TIVA) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Total Intravenous Anesthesia (TIVA) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Total Intravenous Anesthesia (TIVA) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Total Intravenous Anesthesia (TIVA).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Total Intravenous Anesthesia (TIVA) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Total Intravenous Anesthesia (TIVA) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Total Intravenous Anesthesia (TIVA) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Total Intravenous Anesthesia (TIVA) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Total Intravenous Anesthesia (TIVA) Industry Trends Table 2. Total Intravenous Anesthesia (TIVA) Industry Drivers Table 3. Total Intravenous Anesthesia (TIVA) Industry Opportunities and Challenges Table 4. Total Intravenous Anesthesia (TIVA) Industry Restraints Table 5. Global Total Intravenous Anesthesia (TIVA) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Total Intravenous Anesthesia (TIVA) Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Manufacturers Table 9. Global Total Intravenous Anesthesia (TIVA) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Total Intravenous Anesthesia (TIVA) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Total Intravenous Anesthesia (TIVA) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Total Intravenous Anesthesia (TIVA) Manufacturers, Product Type & Application Table 13. Global Total Intravenous Anesthesia (TIVA) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Total Intravenous Anesthesia (TIVA) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Barbiturates Table 17. Major Manufacturers of Propofol Table 18. Major Manufacturers of Midazolam Table 19. Major Manufacturers of Etomidate Table 20. Major Manufacturers of Others Table 21. Global Total Intravenous Anesthesia (TIVA) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Total Intravenous Anesthesia (TIVA) Sales by Type (2021-2026) & (K Units) Table 23. Global Total Intravenous Anesthesia (TIVA) Sales by Type (2027-2032) & (K Units) Table 24. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2021-2026) Table 25. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2027-2032) Table 26. Global Total Intravenous Anesthesia (TIVA) Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Total Intravenous Anesthesia (TIVA) Revenue by Type (2021-2026) & (K Units) Table 28. Global Total Intravenous Anesthesia (TIVA) Revenue by Type (2027-2032) & (K Units) Table 29. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type (2021-2026) Table 30. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Orthopedic Table 32. Major Manufacturers of Cosmetic Surgeries Table 33. Major Manufacturers of Predominantly Emergency Table 34. Major Manufacturers of Others Table 35. Global Total Intravenous Anesthesia (TIVA) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Total Intravenous Anesthesia (TIVA) Sales by Application (2021-2026) & (K Units) Table 37. Global Total Intravenous Anesthesia (TIVA) Sales by Application (2027-2032) & (K Units) Table 38. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2021-2026) Table 39. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2027-2032) Table 40. Global Total Intravenous Anesthesia (TIVA) Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global Total Intravenous Anesthesia (TIVA) Revenue by Application (2021-2026) & (K Units) Table 42. Global Total Intravenous Anesthesia (TIVA) Revenue by Application (2027-2032) & (K Units) Table 43. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application (2021-2026) Table 44. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application (2027-2032) Table 45. Global Total Intravenous Anesthesia (TIVA) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Total Intravenous Anesthesia (TIVA) Sales by Region (2021-2026) & (K Units) Table 47. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Region (2021-2026) Table 48. Global Total Intravenous Anesthesia (TIVA) Sales Forecasted by Region (2027-2032) & (K Units) Table 49. Global Total Intravenous Anesthesia (TIVA) Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Total Intravenous Anesthesia (TIVA) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. North America Total Intravenous Anesthesia (TIVA) Sales by Country (2021-2026) & (K Units) Table 52. North America Total Intravenous Anesthesia (TIVA) Sales by Country (2027-2032) & (K Units) Table 53. Europe Total Intravenous Anesthesia (TIVA) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Europe Total Intravenous Anesthesia (TIVA) Sales by Country (2021-2026) & (K Units) Table 55. Europe Total Intravenous Anesthesia (TIVA) Sales by Country (2027-2032) & (K Units) Table 56. Asia Pacific Total Intravenous Anesthesia (TIVA) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Asia Pacific Total Intravenous Anesthesia (TIVA) Sales by Country (2021-2026) & (K Units) Table 58. Asia Pacific Total Intravenous Anesthesia (TIVA) Sales by Country (2027-2032) & (K Units) Table 59. South America, Middle East and Africa Total Intravenous Anesthesia (TIVA) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. South America, Middle East and Africa Total Intravenous Anesthesia (TIVA) Sales by Country (2021-2026) & (K Units) Table 61. South America, Middle East and Africa Total Intravenous Anesthesia (TIVA) Sales by Country (2027-2032) & (K Units) Table 62. Global Total Intravenous Anesthesia (TIVA) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Total Intravenous Anesthesia (TIVA) Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Total Intravenous Anesthesia (TIVA) Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region (2021-2026) Table 66. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region (2027-2032) Table 67. Mylan Company Information Table 68. Mylan Business Overview Table 69. Mylan Total Intravenous Anesthesia (TIVA) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Mylan Total Intravenous Anesthesia (TIVA) Product Portfolio Table 71. Mylan Recent Development Table 72. Hengrui Company Information Table 73. Hengrui Business Overview Table 74. Hengrui Total Intravenous Anesthesia (TIVA) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Hengrui Total Intravenous Anesthesia (TIVA) Product Portfolio Table 76. Hengrui Recent Development Table 77. B. Braun Medical Company Information Table 78. B. Braun Medical Business Overview Table 79. B. Braun Medical Total Intravenous Anesthesia (TIVA) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. B. Braun Medical Total Intravenous Anesthesia (TIVA) Product Portfolio Table 81. B. Braun Medical Recent Development Table 82. AbbVie Company Information Table 83. AbbVie Business Overview Table 84. AbbVie Total Intravenous Anesthesia (TIVA) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. AbbVie Total Intravenous Anesthesia (TIVA) Product Portfolio Table 86. AbbVie Recent Development Table 87. Astrazeneca Company Information Table 88. Astrazeneca Business Overview Table 89. Astrazeneca Total Intravenous Anesthesia (TIVA) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Astrazeneca Total Intravenous Anesthesia (TIVA) Product Portfolio Table 91. Astrazeneca Recent Development Table 92. Piramal Company Information Table 93. Piramal Business Overview Table 94. Piramal Total Intravenous Anesthesia (TIVA) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Piramal Total Intravenous Anesthesia (TIVA) Product Portfolio Table 96. Piramal Recent Development Table 97. Nhwa Company Information Table 98. Nhwa Business Overview Table 99. Nhwa Total Intravenous Anesthesia (TIVA) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Nhwa Total Intravenous Anesthesia (TIVA) Product Portfolio Table 101. Nhwa Recent Development Table 102. Maruishi Company Information Table 103. Maruishi Business Overview Table 104. Maruishi Total Intravenous Anesthesia (TIVA) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Maruishi Total Intravenous Anesthesia (TIVA) Product Portfolio Table 106. Maruishi Recent Development Table 107. Lunan Company Information Table 108. Lunan Business Overview Table 109. Lunan Total Intravenous Anesthesia (TIVA) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Lunan Total Intravenous Anesthesia (TIVA) Product Portfolio Table 111. Lunan Recent Development Table 112. Hikma Pharmaceuticals Company Information Table 113. Hikma Pharmaceuticals Business Overview Table 114. Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Product Portfolio Table 116. Hikma Pharmaceuticals Recent Development Table 117. Fresenius-Kabi Company Information Table 118. Fresenius-Kabi Business Overview Table 119. Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Product Portfolio Table 121. Fresenius-Kabi Recent Development Table 122. Baxter Healthcare Company Information Table 123. Baxter Healthcare Business Overview Table 124. Baxter Healthcare Total Intravenous Anesthesia (TIVA) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Baxter Healthcare Total Intravenous Anesthesia (TIVA) Product Portfolio Table 126. Baxter Healthcare Recent Development Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Total Intravenous Anesthesia (TIVA) Distributors List Table 130. Total Intravenous Anesthesia (TIVA) Customers List Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Total Intravenous Anesthesia (TIVA) Product Image Figure 2. Global Total Intravenous Anesthesia (TIVA) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Total Intravenous Anesthesia (TIVA) Market Size (2021-2032) & (US$ Million) Figure 4. Global Total Intravenous Anesthesia (TIVA) Sales (2021-2032) & (K Units) Figure 5. Global Total Intravenous Anesthesia (TIVA) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Total Intravenous Anesthesia (TIVA) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Barbiturates Image Figure 9. Propofol Image Figure 10. Midazolam Image Figure 11. Etomidate Image Figure 12. Others Image Figure 13. Global Total Intravenous Anesthesia (TIVA) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Total Intravenous Anesthesia (TIVA) Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2021-2032) Figure 16. Global Total Intravenous Anesthesia (TIVA) Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type (2021-2032) Figure 19. Orthopedic Image Figure 20. Cosmetic Surgeries Image Figure 21. Predominantly Emergency Image Figure 22. Others Image Figure 23. Global Total Intravenous Anesthesia (TIVA) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Total Intravenous Anesthesia (TIVA) Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2021-2032) Figure 26. Global Total Intravenous Anesthesia (TIVA) Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application (2021-2032) Figure 29. North America Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 30. North America Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2021-2032) Figure 31. U.S. Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Canada Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Mexico Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2021-2032) Figure 36. Germany Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 37. France Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 38. U.K. Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Italy Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Netherlands Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2021-2032) Figure 43. China Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Japan Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South Korea Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Southeast Asia Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 47. India Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Australia Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2021-2032) Figure 51. Brazil Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South Africa Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Saudi Arabia Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Turkey Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Argentina Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 56. UAE Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Egypt Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Chile Total Intravenous Anesthesia (TIVA) Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Global Total Intravenous Anesthesia (TIVA) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Figure 62. North America Total Intravenous Anesthesia (TIVA) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Figure 64. Europe Total Intravenous Anesthesia (TIVA) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Total Intravenous Anesthesia (TIVA) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Total Intravenous Anesthesia (TIVA) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Total Intravenous Anesthesia (TIVA) Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Total Intravenous Anesthesia (TIVA) Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Barbiturates
  • Propofol
  • Midazolam
  • Etomidate
  • Others
Applications
  • Orthopedic
  • Cosmetic Surgeries
  • Predominantly Emergency
  • Others
Companies covered
  • Mylan
  • Hengrui
  • B. Braun Medical
  • AbbVie
  • Astrazeneca
  • Piramal
  • Nhwa
  • Maruishi
  • Lunan
  • Hikma Pharmaceuticals
  • Fresenius-Kabi
  • Baxter Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Total Intravenous Anesthesia (TIVA) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Total Intravenous Anesthesia (TIVA) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Total Intravenous Anesthesia (TIVA) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Total Intravenous Anesthesia (TIVA) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Total Intravenous Anesthesia (TIVA) Market Dynamics
  1. 2.1 Total Intravenous Anesthesia (TIVA) Industry Trends
  2. 2.2 Total Intravenous Anesthesia (TIVA) Industry Drivers
  3. 2.3 Total Intravenous Anesthesia (TIVA) Industry Opportunities and Challenges
  4. 2.4 Total Intravenous Anesthesia (TIVA) Industry Restraints
3 Total Intravenous Anesthesia (TIVA) Market by Manufacturers
  1. 3.1 Global Total Intravenous Anesthesia (TIVA) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Total Intravenous Anesthesia (TIVA) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Total Intravenous Anesthesia (TIVA) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Total Intravenous Anesthesia (TIVA) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Total Intravenous Anesthesia (TIVA) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Total Intravenous Anesthesia (TIVA) Manufacturers, Product Type & Application
  7. 3.7 Global Total Intravenous Anesthesia (TIVA) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Total Intravenous Anesthesia (TIVA) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Total Intravenous Anesthesia (TIVA) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Total Intravenous Anesthesia (TIVA) Tier 1, Tier 2, and Tier 3
4 Total Intravenous Anesthesia (TIVA) Market by Type
  1. 4.1 Total Intravenous Anesthesia (TIVA) Type Introduction
  2. 4.1.1 Barbiturates
  3. 4.1.2 Propofol
  4. 4.1.3 Midazolam
  5. 4.1.4 Etomidate
  6. 4.1.5 Others
  7. 4.2 Global Total Intravenous Anesthesia (TIVA) Sales by Type
  8. 4.2.1 Global Total Intravenous Anesthesia (TIVA) Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Total Intravenous Anesthesia (TIVA) Sales by Type (2021-2032)
  10. 4.2.3 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2021-2032)
  11. 4.3 Global Total Intravenous Anesthesia (TIVA) Revenue by Type
  12. 4.3.1 Global Total Intravenous Anesthesia (TIVA) Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Total Intravenous Anesthesia (TIVA) Revenue by Type (2021-2032)
  14. 4.3.3 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type (2021-2032)
5 Total Intravenous Anesthesia (TIVA) Market by Application
  1. 5.1 Total Intravenous Anesthesia (TIVA) Application Introduction
  2. 5.1.1 Orthopedic
  3. 5.1.2 Cosmetic Surgeries
  4. 5.1.3 Predominantly Emergency
  5. 5.1.4 Others
  6. 5.2 Global Total Intravenous Anesthesia (TIVA) Sales by Application
  7. 5.2.1 Global Total Intravenous Anesthesia (TIVA) Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Total Intravenous Anesthesia (TIVA) Sales by Application (2021-2032)
  9. 5.2.3 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2021-2032)
  10. 5.3 Global Total Intravenous Anesthesia (TIVA) Revenue by Application
  11. 5.3.1 Global Total Intravenous Anesthesia (TIVA) Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Total Intravenous Anesthesia (TIVA) Revenue by Application (2021-2032)
  13. 5.3.3 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application (2021-2032)
6 Global Total Intravenous Anesthesia (TIVA) Sales by Region
  1. 6.1 Global Total Intravenous Anesthesia (TIVA) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Total Intravenous Anesthesia (TIVA) Sales by Region (2021-2032)
  3. 6.2.1 Global Total Intravenous Anesthesia (TIVA) Sales by Region (2021-2026)
  4. 6.2.2 Global Total Intravenous Anesthesia (TIVA) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Total Intravenous Anesthesia (TIVA) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Total Intravenous Anesthesia (TIVA) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Total Intravenous Anesthesia (TIVA) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Total Intravenous Anesthesia (TIVA) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Total Intravenous Anesthesia (TIVA) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Total Intravenous Anesthesia (TIVA) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Total Intravenous Anesthesia (TIVA) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Total Intravenous Anesthesia (TIVA) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Total Intravenous Anesthesia (TIVA) Revenue by Region
  1. 7.1 Global Total Intravenous Anesthesia (TIVA) Revenue by Region
  2. 7.1.1 Global Total Intravenous Anesthesia (TIVA) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Total Intravenous Anesthesia (TIVA) Revenue by Region (2021-2026)
  4. 7.1.3 Global Total Intravenous Anesthesia (TIVA) Revenue by Region (2027-2032)
  5. 7.1.4 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Total Intravenous Anesthesia (TIVA) Revenue (2021-2032)
  8. 7.2.2 North America Total Intravenous Anesthesia (TIVA) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Total Intravenous Anesthesia (TIVA) Revenue (2021-2032)
  11. 7.3.2 Europe Total Intravenous Anesthesia (TIVA) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Total Intravenous Anesthesia (TIVA) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Total Intravenous Anesthesia (TIVA) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Total Intravenous Anesthesia (TIVA) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Total Intravenous Anesthesia (TIVA) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Mylan
  2. 8.1.1 Mylan Company Information
  3. 8.1.2 Mylan Business Overview
  4. 8.1.3 Mylan Total Intravenous Anesthesia (TIVA) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Mylan Total Intravenous Anesthesia (TIVA) Product Portfolio
  6. 8.1.5 Mylan Recent Developments
  7. 8.2 Hengrui
  8. 8.2.1 Hengrui Company Information
  9. 8.2.2 Hengrui Business Overview
  10. 8.2.3 Hengrui Total Intravenous Anesthesia (TIVA) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hengrui Total Intravenous Anesthesia (TIVA) Product Portfolio
  12. 8.2.5 Hengrui Recent Developments
  13. 8.3 B. Braun Medical
  14. 8.3.1 B. Braun Medical Company Information
  15. 8.3.2 B. Braun Medical Business Overview
  16. 8.3.3 B. Braun Medical Total Intravenous Anesthesia (TIVA) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 B. Braun Medical Total Intravenous Anesthesia (TIVA) Product Portfolio
  18. 8.3.5 B. Braun Medical Recent Developments
  19. 8.4 AbbVie
  20. 8.4.1 AbbVie Company Information
  21. 8.4.2 AbbVie Business Overview
  22. 8.4.3 AbbVie Total Intravenous Anesthesia (TIVA) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AbbVie Total Intravenous Anesthesia (TIVA) Product Portfolio
  24. 8.4.5 AbbVie Recent Developments
  25. 8.5 Astrazeneca
  26. 8.5.1 Astrazeneca Company Information
  27. 8.5.2 Astrazeneca Business Overview
  28. 8.5.3 Astrazeneca Total Intravenous Anesthesia (TIVA) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Astrazeneca Total Intravenous Anesthesia (TIVA) Product Portfolio
  30. 8.5.5 Astrazeneca Recent Developments
  31. 8.6 Piramal
  32. 8.6.1 Piramal Company Information
  33. 8.6.2 Piramal Business Overview
  34. 8.6.3 Piramal Total Intravenous Anesthesia (TIVA) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Piramal Total Intravenous Anesthesia (TIVA) Product Portfolio
  36. 8.6.5 Piramal Recent Developments
  37. 8.7 Nhwa
  38. 8.7.1 Nhwa Company Information
  39. 8.7.2 Nhwa Business Overview
  40. 8.7.3 Nhwa Total Intravenous Anesthesia (TIVA) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nhwa Total Intravenous Anesthesia (TIVA) Product Portfolio
  42. 8.7.5 Nhwa Recent Developments
  43. 8.8 Maruishi
  44. 8.8.1 Maruishi Company Information
  45. 8.8.2 Maruishi Business Overview
  46. 8.8.3 Maruishi Total Intravenous Anesthesia (TIVA) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Maruishi Total Intravenous Anesthesia (TIVA) Product Portfolio
  48. 8.8.5 Maruishi Recent Developments
  49. 8.9 Lunan
  50. 8.9.1 Lunan Company Information
  51. 8.9.2 Lunan Business Overview
  52. 8.9.3 Lunan Total Intravenous Anesthesia (TIVA) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lunan Total Intravenous Anesthesia (TIVA) Product Portfolio
  54. 8.9.5 Lunan Recent Developments
  55. 8.10 Hikma Pharmaceuticals
  56. 8.10.1 Hikma Pharmaceuticals Company Information
  57. 8.10.2 Hikma Pharmaceuticals Business Overview
  58. 8.10.3 Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Product Portfolio
  60. 8.10.5 Hikma Pharmaceuticals Recent Developments
  61. 8.11 Fresenius-Kabi
  62. 8.11.1 Fresenius-Kabi Company Information
  63. 8.11.2 Fresenius-Kabi Business Overview
  64. 8.11.3 Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Product Portfolio
  66. 8.11.5 Fresenius-Kabi Recent Developments
  67. 8.12 Baxter Healthcare
  68. 8.12.1 Baxter Healthcare Company Information
  69. 8.12.2 Baxter Healthcare Business Overview
  70. 8.12.3 Baxter Healthcare Total Intravenous Anesthesia (TIVA) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Baxter Healthcare Total Intravenous Anesthesia (TIVA) Product Portfolio
  72. 8.12.5 Baxter Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Total Intravenous Anesthesia (TIVA) Value Chain Analysis
  2. 9.1.1 Total Intravenous Anesthesia (TIVA) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Total Intravenous Anesthesia (TIVA) Production Mode & Process
  6. 9.2 Total Intravenous Anesthesia (TIVA) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Total Intravenous Anesthesia (TIVA) Distributors
  9. 9.2.3 Total Intravenous Anesthesia (TIVA) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst